ConductScience.org, home

Paper36977246

Effects of Oral 5-Aminolevulinic Acid on Lipopolysaccharide-Induced Ocular Inflammation in Rats.

Otaka Y and 6 others. Vet Sci, 2023. Cited by 7 papers, by iCite.

Cite this record

ConductScience Library. Effects of Oral 5-Aminolevulinic Acid on Lipopolysaccharide-Induced Ocular Inflammation in Rats. Papers, record 36977246. Release papers-2026-11-12-0.1.0, 12 Nov 2026. https://conductscience.org/library/papers/36977246

Download JSON
Sources
11 sources
Release
papers-2026-11-12-0.1.0

Paper

PubMed's record of the paper, with iCite's citation figures. No abstract is shown.

Title
Effects of Oral 5-Aminolevulinic Acid on Lipopolysaccharide-Induced Ocular Inflammation in Rats.
PubMed
Journal
Vet Sci
PubMed
Year
2023
PubMed
Publication types
Journal Article
PubMed
Citations, by iCite
7
iCite
Relative citation ratio, by iCite
1.19
iCite
Revised in PubMed
2023-03-31
PubMed

Authors7

The authors in the order PubMed's record lists them, with the ORCID iDs it states.

OrderAuthorForenameKindORCID iD
1Otaka YYuya
2Kanai KKazutakahttps://orcid.org/0000-0003-3690-2332
3Okada DDaiki
4Nagai NNoriaki
5Yamashita YYohei
6Ichikawa YYoichiro
7Tajima KKazukihttps://orcid.org/0000-0002-2663-471X

Source PubMed

Download CSV of authors

Topics0

NLM's MeSH indexing of the paper, its major topics first.

None in this release.

Grants1

Each grant PubMed's record writes, matched to the NIH project NIH's grant and paper links name for this paper, and each of those links the record does not write.

Grant, as the record writes itAgencyCountryNIH projectStated by
2020-06469Neopharma Japan Co., Ltd.PubMed

Source PubMed

Download CSV of grants

References40

The papers the reference list in PubMed's record names, those in our copy of PubMed, in the list's order.

OrderPMIDTitleJournalYearIn PapersSource
18125720Kinetics of intraocular tumor necrosis factor and interleukin-6 in endotoxin-induced uveitis in the rat.Invest Ophthalmol Vis Sci1994https://conductscience.org/library/papers/8125720PubMed
221144919Novel development of 5-aminolevurinic acid (ALA) in cancer diagnoses and therapy.Int Immunopharmacol2011https://conductscience.org/library/papers/21144919PubMed
325093862Green tea extract treatment alleviates ocular inflammation in a rat model of endotoxin-induced uveitis.PLoS One2014https://conductscience.org/library/papers/25093862PubMed
41544781Endotoxin-induced uveitis in the rat. The significance of intraocular interleukin-6.Invest Ophthalmol Vis Sci1992https://conductscience.org/library/papers/1544781PubMed
522883608Use of the dietary supplement 5-aminiolevulinic acid (5-ALA) and its relationship with glucose levels and hemoglobin A1C among individuals with prediabetes.Clin Transl Sci2012https://conductscience.org/library/papers/22883608PubMed
617898287Aldose reductase inhibition prevents endotoxin-induced uveitis in rats.Invest Ophthalmol Vis Sci2007https://conductscience.org/library/papers/17898287PubMed
733424865Ocular Microbiota and Intraocular Inflammation.Front Immunol2020https://conductscience.org/library/papers/33424865PubMed
836142138Exploring the Healthy Eye Microbiota Niche in a Multicenter Study.Int J Mol Sci2022https://conductscience.org/library/papers/36142138PubMed
933510636The Anti-Inflammatory Effect of KS23, A Novel Peptide Derived From Globular Adiponectin, on Endotoxin-Induced Uveitis in Rats.Front Pharmacol2020https://conductscience.org/library/papers/33510636PubMed
10305674995-Aminolevulinic acid regulates the immune response in LPS-stimulated RAW 264.7 macrophages.BMC Immunol2018https://conductscience.org/library/papers/30567499PubMed
118155054The role of nitric oxide in uveitis.Arch Ophthalmol1994https://conductscience.org/library/papers/8155054PubMed
1215623784Anti-inflammatory effects of aronia extract on rat endotoxin-induced uveitis.Invest Ophthalmol Vis Sci2005https://conductscience.org/library/papers/15623784PubMed
139893027Basic pathogenic mechanisms operating in experimental models of acute anterior uveitis.Immunol Cell Biol1998https://conductscience.org/library/papers/9893027PubMed
1411024423Guidelines for the use of immunosuppressive drugs in patients with ocular inflammatory disorders: recommendations of an expert panel.Am J Ophthalmol2000https://conductscience.org/library/papers/11024423PubMed
1533864579Protective effect of filgotinib in rat endotoxin-induced uveitis model.Int Ophthalmol2021https://conductscience.org/library/papers/33864579PubMed
168125755Cytokine mRNA levels in rat ocular tissues after systemic endotoxin treatment.Invest Ophthalmol Vis Sci1994https://conductscience.org/library/papers/8125755PubMed
1724697218Effects of topical indomethacin, bromfenac and nepafenac on lipopolysaccharide-induced ocular inflammation.J Pharm Pharmacol2014https://conductscience.org/library/papers/24697218PubMed
1833464920Various aspects of sex and gender bias in biomedical research.Physiol Res2020https://conductscience.org/library/papers/33464920PubMed
1924987987Gender disparities in ocular inflammatory disorders.Curr Eye Res2015https://conductscience.org/library/papers/24987987PubMed
208631633Expression of inducible nitric oxide synthase in the eye from endotoxin-induced uveitis rats.Invest Ophthalmol Vis Sci1996https://conductscience.org/library/papers/8631633PubMed

See all 40 referencesDownload CSV of references

Cited by3

The papers in our copy of PubMed whose reference list names this one, newest first. iCite, which reads more sources, counts 7 citations.

PMIDTitleJournalYearIn PapersSource
39720526Therapeutic potential of 5-aminolevulinic acid in metabolic disorders: Current insights and future directions.iScience2024https://conductscience.org/library/papers/39720526PubMed
38347961
Curcuma longa extract reduces serum inflammatory markers and postprandial hyperglycemia in healthy but borderline participants with overweight and glycemia in the normal/prediabetes range: a randomized, double-blind, and placebo-controlled trial.
Front Nutr2024https://conductscience.org/library/papers/38347961PubMed
372399955-ALA/SFC Ameliorates Endotoxin-Induced Ocular Inflammation in Rats by Inhibiting the NF-κB Signaling Pathway and Activating the HO-1/Nrf2 Signaling Pathway.Int J Mol Sci2023https://conductscience.org/library/papers/37239995PubMed

Download CSV of cited by

Data dates

The date of each source this release read.

PubMed
2026-11-06
PubMed
iCite
2026-11-05
iCite
PMC's ID file
2026-11-05
PMC's ID file
NIH RePORTER's grant and paper links
2026-11-01
NIH RePORTER's grant and paper links
Trials
2026-11-12
Gene search
2026-11-11
Pipelines
2026-09-18

None in this release

  • Trials
  • Comments and corrections
  • Genes
  • Drugs
  • Data

Sources 11

  • ChEMBL, through Open TargetsCC BY-SA 3.0
  • ClinicalTrials.govNo license stated
  • HGNCCC0
  • iCiteCC BY 4.0
  • NCBI GenePublic domain (US government)
  • NIH RePORTER's grant and paper linksPublic domain
  • Open TargetsCC0 1.0
  • PMC's ID filePublic domain (US government)
  • PubMedNLM's terms
  • PubTator 3Public domain
  • UniProtCC BY 4.0
Each source's terms
  • ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
  • ClinicalTrials.govnone stated
  • HGNCCC0: https://www.genenames.org/about/license/
  • iCiteCC BY 4.0
  • NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
  • NIH RePORTER's grant and paper linksPublic domain (NIH RePORTER)
  • Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
  • PMC's ID fileNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
  • PubMedNLM's terms
  • PubTator 3Public domain
  • UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license

ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.

For software

Read this paper from software.

The record and each of its lists are JSON, twenty rows a page. No key.

GET https://conductscience.org/api/papers/v1/36977246

GET https://conductscience.org/api/papers/v1/36977246/references?page=2